ACT for Spinal Cord Injury in India: Neuroregeneration and Functional Recovery | ALIV

ALIV Pune ACT spinal cord injury — doctor explaining autologous cell therapy neuroregeneration to spinal cord injury patient and family

News & Insights

May 15, 2026

Spinal cord injury (SCI) — whether from road accidents, falls, or sports trauma — produces neurological deficits whose severity and permanence depend on whether the injury is complete (no motor or sensory function below the level) or incomplete (partial preservation of function). The acute management of SCI is hospital-based: surgical stabilisation, decompression where appropriate, and intensive rehabilitation. ALIV's ACT programme for SCI addresses the subacute and chronic phases — supporting the neuroplastic and neuroregenerative processes that determine how much function can be recovered in the months to years after the injury.

The Neurobiology of SCI and the ACT Target

SCI produces its functional deficits through two mechanisms: primary mechanical damage (neurons severed or crushed at the moment of injury) and secondary injury cascade (inflammatory, ischaemic, and excitotoxic damage that expands the injury zone in the hours, days, and weeks that follow). The secondary cascade creates a peri-injury zone of damaged but potentially recoverable tissue — analogous to the peri-infarct zone in stroke. This is the primary ACT target: the tissue that is impaired rather than destroyed, where neuroplasticity and partial axonal regeneration remain possible if the hostile inflammatory environment is modulated.

ALIV's ACT preparation for SCI delivers: BDNF and GDNF (supporting axonal regeneration and Schwann cell activity); anti-inflammatory MSC paracrine signals (reducing the chronic neuroinflammation that sustains secondary damage); VEGF (restoring microvascular supply to the peri-injury cord); and IGF-1 (supporting neuronal metabolic function and survival). Administration is via IV infusion for systemic and peri-lesional delivery — the systemic anti-inflammatory effect reaching the cord via systemic circulation. See: ACT mechanism explained.

Who Benefits Most — and Honest Expectations

The ACT-SCI clinical profile that responds most meaningfully: incomplete SCI (some residual function preserved — American Spinal Injury Association grade C or D); injury at least three months prior (acute phase neuroinflammation has stabilised); active engagement in physiotherapy and rehabilitation; and neurologically stable for at least two months before ACT. Complete SCI (ASIA grade A — no motor or sensory preservation below injury level) with no signs of recovery at twelve months carries the most limited regenerative prognosis — ACT in this group may support systemic wellbeing and prevent progressive secondary complications but is unlikely to restore significant motor function. The pre-ACT consultation assesses SCI grade, imaging, time since injury, and rehabilitation trajectory to determine the realistic clinical picture for each individual patient.

How soon after a spinal cord injury can ACT start?

A minimum of three months post-injury is ALIV's clinical position — and for most patients, six to twelve months after the injury (once neurological stability is established and rehabilitation baseline is defined) is the more common timing. Very early post-SCI ACT is not part of ALIV's programme: the acute inflammatory cascade of SCI is complex, and introducing growth factors into an acutely evolving injury environment carries uncertain risks. The subacute and early chronic phases — when the secondary injury cascade has resolved but the window for neuroplastic recovery remains open — are the most appropriate treatment windows.

Can ACT restore complete paralysis?

For complete SCI with no preserved function — ASIA grade A — meaningful motor restoration from ACT is not a realistic clinical expectation with current protocols. What ACT can support in complete SCI: prevention of progressive secondary complications; improved autonomic function (bladder, bowel, cardiovascular stability) where preserved autonomic pathways remain; and systemic anti-inflammatory and metabolic wellbeing improvements that support quality of life and rehabilitation engagement. For incomplete SCI, meaningful motor and sensory function improvements — additional recovery beyond what rehabilitation alone produces — are the realistic clinical goal.

Should ACT replace rehabilitation for SCI?

No. Rehabilitation — physiotherapy, occupational therapy, and for cervical injuries, respiratory therapy — is the evidence-based foundation of SCI recovery and must continue alongside ACT, not be replaced by it. ACT creates a more favourable neurological environment for rehabilitation gains; rehabilitation provides the neural activity that drives the plasticity ACT is supporting. Patients who receive ACT without continuing intensive rehabilitation produce significantly less benefit than those who engage both simultaneously.

Get in touch

book-now